HIGHLIGHTS
- who: Fabiola De Luca and collaborators from the Department of Chemical, Biological, Pharmaceutical and Environmental Chemistry, University of Messina, Viale FStagno d`Alcontres, Messina, Italy have published the Article: Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma, in the Journal: (JOURNAL)
- what: DTT is currently the approach that is used the most . The phase 1b study TCD11863- NCT01749969, the primary objective of which was to determine the maximum tolerated dose, is an open-label, dose escalation study that evaluated the safety, efficacy, and pharmacokinetics of anti-CD38 monoclonal antibody administered in 2 schedules in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.